On November 14, 2022, Dr. Cato Laurencin, the CEO of The Connecticut Convergence Institute and the Regenerative Engineering Society (RES), celebrated ten years of Regenerative Engineering.
Regenerative engineering combines advanced materials sciences, stem cell science, physics, developmental biology, and clinical translation to regenerate complex tissues and organ systems. Embedded in this new field include the following five areas: Advanced Materials Sciences, Stem Cell Sciences, Physics, Developmental Biology, and Clinical Translation.
When parts of organs are destroyed, it is difficult to completely repair or regenerate. Wounds undergo fibrosis because of intense inflammatory reactions, eventually settling down, hardening or scarring. This research field is interested in the study of the mechanisms underlying fibrosis in various organs and the research and development of fibrosis control technologies for therapeutic purposes. This type of breakthrough will tremendously impact public health and the lives of those with amputations due to bone cancer, diabetes, dangerous infections, trauma accidents, or even children born with missing or impaired limbs.
Dr. Cato Laurencin and the Connecticut Convergence Institute team have conducted many journals, studies, and articles. You can find the latest publications and journals on the website: health.uconn.edu/regenerative-engineering-institute.
